CollPlant gains $10m milestone from AbbVie to develop dermal and soft tissue filler
Longevity Technology - 04-Jul-2023Recombinant human collagen based fillers help advance the field regenerative aesthetics
Yehiel Tal
Chief Executive Officer at CollPlant.
Yehiel is a seasoned executive in the biomedical field and brings over two decades of management experience in both high-tech and biotech companies. He joined CollPlant in 2010 and prior to this, Yehiel served as CEO and Co-founder of Regentis Biomaterials Ltd.; Vice-President of Business Development at ProChon BioTech Ltd.; Vice President of Marketing and Business Development at OrthoScan Technologies Ltd.; and Director of Business Development and Business Unit Manager at Kulicke and Soffa Industries, Inc. Yehiel holds a BSc and an MSc degree in Mechanical Engineering from the Technion-Israel Institute of Technology.
Visit website: https://collplant.com/about/
See also
CollPlant
Regenerative and aesthetic medicine company focused on medical aesthetics and 3D bioprinting of tissues and organs.
Details last updated 08-May-2020
Yehiel Tal News
Israel's CollPlant to improve 3D bioprinted organs
3ders - 20-Oct-2017Received $5M investment from Martin Schlaff's Alpha Capital. Bioprinted tissues based on technol...